Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)

SHE:301258 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	302.48	224.73	349.74	259.69	332.06	98.09
Trading Asset Securities	1,028	1,123	1,070	1,161	21.61	120
Cash & Short-Term Investments	1,330	1,348	1,419	1,421	353.67	218.09
Cash Growth	-4.81%	-5.04%	-0.10%	301.69%	62.17%	0.96%
Accounts Receivable	140.57	101.35	62.91	97.02	87.87	79.73
Other Receivables	0.87	0.84	0.93	0.85	2.05	1.45
Receivables	141.45	102.19	63.84	97.87	89.92	81.18
Inventory	148.13	154.83	157.09	122.69	68.6	60.12
Other Current Assets	7.66	6.75	8.59	8.55	4.41	13.6
Total Current Assets	1,627	1,612	1,649	1,650	516.6	372.98
Property, Plant & Equipment	388.9	398.91	387.62	416.11	421.15	381.61
Long-Term Investments	-	5	26.27	-	-	-
Other Intangible Assets	62.09	62.56	21.24	21.97	22.07	22.7
Long-Term Deferred Tax Assets	0.07	0.07	0.01	0	1.61	1.35
Long-Term Deferred Charges	2.96	3.28	4.55	-	-	-
Other Long-Term Assets	31.1	6.34	27.58	10.49	8.88	9.61
Total Assets	2,113	2,088	2,116	2,098	970.31	788.25
Accounts Payable	126.7	118.25	84.97	114.86	124.96	90.86
Accrued Expenses	8.99	19.16	19.48	18.47	17.85	15.71
Short-Term Debt	-	-	-	-	18.58	-
Current Portion of Leases	0.68	0.66	0.59	0.56	-	-
Current Income Taxes Payable	2.77	4.49	1.33	3.4	3.9	-
Current Unearned Revenue	5.19	1.42	2.07	6.49	6.73	3.49
Other Current Liabilities	1.26	1.27	3.66	6.12	1.15	0.92
Total Current Liabilities	145.58	145.25	112.1	149.91	173.17	110.98
Long-Term Leases	0.84	1.01	1.67	2.25	-	-
Long-Term Unearned Revenue	36.22	36.99	35.27	38.38	36.42	38.95
Long-Term Deferred Tax Liabilities	19.64	17.6	21.41	21.21	17.88	15.68
Total Liabilities	202.28	200.84	170.45	211.75	227.47	165.61
Common Stock	91.67	91.67	91.67	91.67	68.75	68.75
Additional Paid-In Capital	1,144	1,144	1,144	1,144	163.42	163.42
Retained Earnings	695.69	671.75	710.32	651.31	510.67	390.47
Treasury Stock	-20.81	-20.14	-	-	-	-
Shareholders' Equity	1,910	1,887	1,946	1,887	742.84	622.64
Total Liabilities & Equity	2,113	2,088	2,116	2,098	970.31	788.25
Total Debt	1.51	1.67	2.25	2.82	18.58	-
Net Cash (Debt)	1,329	1,346	1,417	1,418	335.09	218.09
Net Cash Growth	-4.78%	-5.00%	-0.06%	323.12%	53.65%	0.96%
Net Cash Per Share	14.61	14.77	15.41	16.47	4.88	3.17
Filing Date Shares Outstanding	90.79	90.82	91.67	91.67	68.75	68.75
Total Common Shares Outstanding	90.79	90.82	91.67	91.67	68.75	68.75
Working Capital	1,482	1,466	1,537	1,500	343.43	262
Book Value Per Share	21.04	20.78	21.22	20.58	10.80	9.06
Tangible Book Value	1,848	1,824	1,924	1,865	720.76	599.94
Tangible Book Value Per Share	20.36	20.09	20.99	20.34	10.48	8.73
Buildings	-	254.18	253.42	251.56	253.49	189.23
Machinery	-	470.51	454.95	436.91	384.41	360.9
Construction In Progress	-	38.15	1.49	0.43	12.17	17.58
Order Backlog	-	81.26	-	-	-	-

Updated Oct 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.